Mcf Advisors LLC Kala Pharmaceuticals, Inc. Transaction History

Mcf Advisors LLC

  • $1.42 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 05, 2022
BUY
$0.61 - $1.84 $5,153 - $15,544
8,448 New
8,448 $11,000
Q4 2021

Feb 14, 2022
SELL
$1.16 - $2.74 $9,799 - $23,147
-8,448 Closed
0 $0
Q1 2020

Apr 24, 2020
BUY
$3.83 - $8.79 $32,355 - $74,257
8,448 New
8,448 $74,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Kala Pharmaceuticals, Inc.

KALA Quotes by TradingView
  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $8.67M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Mcf Advisors LLC Portfolio

Follow Mcf Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcf Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email